# Impact of ICCAN on Cancer Treatment Completion and Quality of Life

> **NCT01742143** · — · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 347 (estimated)

## Conditions studied

- Cancer Patients

## Interventions

- **BEHAVIORAL:** The Integrated Cancer Care Access Network (ICCAN)
- **BEHAVIORAL:** Usual and Customary Group (U&C)

## Key facts

- **NCT ID:** NCT01742143
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2012-11
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 347 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01742143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01742143, "Impact of ICCAN on Cancer Treatment Completion and Quality of Life". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01742143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*